CrossBridge Bio
United States
- Houston, Texas
- 05/11/2024
- Unknown
- $10,000,000
CrossBridge Bio is a biotechnology company focused on developing innovative ADC therapeutics using our proprietary stable dual-linker payload technology.
- Industry Biotechnology Research
- Website https://crossbridgebio.com/
- LinkedIn https://www.linkedin.com/company/crossbridge-bio/
Related People
Michael TorresFounder
United States -
Houston, Texas
I have a passion for translating science into medicines. I believe the best mechanism to get new and innovative drugs to patients is through biopharma. To that end, I am a scientist entrepreneur and have successfully taken a project I initiated into a fully-formed venture backed biotech company.
I have a background in equity research and familiarity with sell-side, buy-side analysis. This, coupled with my hands on the bench have driven my passion of turning ideas into companies. I now have experience recruiting talented scientists to co-develop new IP, incorporating, licensing said technology, and raising funds while managing the day to day operations of a startup. While these experiences are important for my personal career, the chance to bring new medicines to underserved patient populations is core to my drive.
Integrate | $17,000,000 | (Feb 13, 2026)
daypass.com | $2,000,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Ever | $31,000,000 | (Feb 13, 2026)
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
Santé(US) | $7,600,000 | (Feb 13, 2026)
Alva Energy | $33,000,000 | (Feb 13, 2026)
Project Omega | $12,000,000 | (Feb 13, 2026)
Brandlight | $30,000,000 | (Feb 12, 2026)
Inertia | $450,000,000 | (Feb 12, 2026)